Myelomonocytic (FAB M4) and/or monocytic (FAB M5) AML subtypes show a higher ATP1A1/BCL2L1 ratio (ATP1A1/BCL2L1high). This evidence concerns the gene ATP1A1 and acute myeloid leukemia.